Statistics
Publications
3
Citations
531
H-Index
3
Active since
2021
Molly Radosevich is an author at Stanford University specializing in antitumor t cell responses, cancer immunology, and immunotherapy.
Publications per year
2021–2024
3
3
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Johanna Theruvath, Marie Ménard, Benjamin Smith et al. · Nature Medicine · 2022 · 255 citations · Full text
Medicine, Immunology, Oncology +13
Engineered CD47 protects T cells for enhanced antitumour immunity
Sean A. Yamada‐Hunter, Johanna Theruvath, Brianna J. McIntosh et al. · Nature · 2024 · 113 citations · Full text
Life Sciences, Immunology, Oncology +17
1–3 of 3